In a move that sent shockwaves through the crypto market, Coinbase has added Bio Protocol (BIO) and Euler (EUL) to its asset roadmap, triggering immediate price surges. Will this be another case of the famous ‘Coinbase effect,’ or is there more to the story?
Coinbase’s Strategic Move: Why BIO and EUL?
Coinbase’s announcement on July 29, 2025, via an X post, revealed the addition of BIO and EUL to its asset roadmap. This signals potential future listings, but what makes these tokens stand out?
- BIO Token: Powers the decentralized science (DeSci) ecosystem, enabling biotech research and IP tokenization through BioDAOs.
- EUL Token: The governance token for Euler Finance, facilitating lending and borrowing of niche crypto assets on Ethereum.
The Immediate Impact: Price Surges and Market Reactions
The news sparked a 17% surge in BIO and a 3.5% rise in EUL, but will these gains hold? Here’s a quick breakdown:
| Token | Initial Surge | Current Status |
|---|---|---|
| BIO | 17% | Retreated slightly |
| EUL | 3.5% | Stable |
The Coinbase Effect: Boon or Bane?
Historically, Coinbase listings have led to short-term volatility. Examples include:
- NEWT token plummeting 44% post-listing.
- VVV token crashing due to pre-listing sales allegations.
Analysts caution that while Coinbase’s credibility often boosts listings, outcomes depend on market conditions and investor sentiment.
What’s Next for BIO and EUL?
Both tokens are already traded on major exchanges like Binance and Kraken, which may limit the long-term impact of a Coinbase listing. However, the addition aligns with Coinbase’s strategy to diversify its offerings, reflecting growing interest in DeSci and DeFi innovations.
Actionable Insights for Traders
Before jumping in, consider:
- Due diligence is crucial—past listings show mixed results.
- Tokens with limited pre-existing liquidity often see sharper rallies.
- Established assets like BIO and EUL may have muted reactions.
Final Thought: While the Coinbase roadmap addition is a bullish signal, traders should remain cautious. The crypto market is unpredictable, and historical precedents suggest that initial gains may not always translate to long-term success.
FAQs
Q: Does Coinbase’s roadmap guarantee a listing?
A: No, inclusion only indicates ongoing evaluation.
Q: Why did BIO surge more than EUL?
A: BIO’s lower liquidity and niche DeSci focus may have amplified its price reaction.
Q: Are BIO and EUL good long-term investments?
A: It depends on market conditions, token utility, and broader adoption trends.
Q: What is the ‘Coinbase effect’?
A: The short-term price rally often seen after a Coinbase listing announcement.
